- Home
- CRBP vs OSUR Comparison
CRBP vs OSUR Comparison
Compare CRBP & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- OSUR
- Stock Information
- Founded
- CRBP 2009
- OSUR 2000
- Country
- CRBP United States
- OSUR United States
- Employees
- CRBP N/A
- OSUR N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- OSUR Medical/Dental Instruments
- Sector
- CRBP Health Care
- OSUR Health Care
- Exchange
- CRBP Nasdaq
- OSUR Nasdaq
- Market Cap
- CRBP 210.8M
- OSUR 177.2M
- IPO Year
- CRBP N/A
- OSUR 1986
- Fundamental
- Price
- CRBP $11.23
- OSUR $2.47
- Analyst Decision
- CRBP Strong Buy
- OSUR Hold
- Analyst Count
- CRBP 9
- OSUR 2
- Target Price
- CRBP $48.38
- OSUR $3.00
- AVG Volume (30 Days)
- CRBP 546.2K
- OSUR 794.1K
- Earning Date
- CRBP 11-12-2025
- OSUR 11-05-2025
- Dividend Yield
- CRBP N/A
- OSUR N/A
- EPS Growth
- CRBP N/A
- OSUR N/A
- EPS
- CRBP N/A
- OSUR N/A
- Revenue
- CRBP N/A
- OSUR $125,703,000.00
- Revenue This Year
- CRBP N/A
- OSUR N/A
- Revenue Next Year
- CRBP $220.00
- OSUR $4.32
- P/E Ratio
- CRBP N/A
- OSUR N/A
- Revenue Growth
- CRBP N/A
- OSUR N/A
- 52 Week Low
- CRBP $4.64
- OSUR $2.08
- 52 Week High
- CRBP $20.56
- OSUR $4.22
- Technical
- Relative Strength Index (RSI)
- CRBP 38.90
- OSUR 46.07
- Support Level
- CRBP $10.88
- OSUR $2.08
- Resistance Level
- CRBP $12.43
- OSUR $2.35
- Average True Range (ATR)
- CRBP 0.76
- OSUR 0.15
- MACD
- CRBP 0.05
- OSUR 0.02
- Stochastic Oscillator
- CRBP 51.59
- OSUR 84.71
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.